CN102539769A - Method for semi-quantitative diagnosis of creatine kinase isoenzyme by double indicating line immuno-chromatography - Google Patents
Method for semi-quantitative diagnosis of creatine kinase isoenzyme by double indicating line immuno-chromatography Download PDFInfo
- Publication number
- CN102539769A CN102539769A CN2011104337275A CN201110433727A CN102539769A CN 102539769 A CN102539769 A CN 102539769A CN 2011104337275 A CN2011104337275 A CN 2011104337275A CN 201110433727 A CN201110433727 A CN 201110433727A CN 102539769 A CN102539769 A CN 102539769A
- Authority
- CN
- China
- Prior art keywords
- line
- detection
- creatine kinase
- antibody
- chromatography
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
The invention discloses a detection method in the technical field of bioengineering, and particularly relates to a method for semi-quantitative diagnosis of creatine kinase isoenzyme by double indicating line immuno-chromatography. Acute myocardial infraction (AMI) is a very severe type of coronary heart diseases, is a common acute disease in middle-aged and aged people, and is high in mortality; statistics shows that about 1/3-1/2 patients are dead before they are sent to a hospital. In the future 20 years, acute myocardial infraction is the first reason causing patient death all around the world. CK-MB is the most reliable 'gold standard' for AMI detection by clinical doctors, and is high in specificity; currently, methods for detecting CK-MB commonly used clinically are enzyme-linked immunosorbent assay, radioimmunoassay, and the like, and the methods are time-consuming, labor-consuming, not in favor of popularization, and high in price. Immune colloidal gold technology develops rapidly recently, and is widely applicable to the detection of infectious diseases, early pregnancy, cancers and the like. The invention adopts colloidal gold immuno-chromatography, and establishes a method for rapid detection of CK-MB. And semi-quantitative detection of CK-MB in a gray area range of 5 ng/mL-10 ng/mL is realized.
Description
Technical field
The present invention relates to a kind of detection method of technical field of bioengineering, specifically is the method for the two index line immunochromatography sxemiquantitative diagnosis of a kind of usefulness creatine kinase isozyme.
Background technology
Along with the raising of China's living standards of the people, high fat of blood, hypertension, evidence of coronary heart diseases also obviously increase.Acute myocardial infarction (acute myocardial infarction; AMI) be a very serious type in the coronary heart disease,, make the part cardiac muscle because of serious and lasting ischemic generation local necrosis for coronary occlusion, blood flow interrupt; Thereby the grievous injury that causes cardiac function; Mortality ratio is higher, according to statistics, has the patient of 1/3-1/2 dead before delivering to hospital approximately.Acute myocardial infarction sees that the America and Europe China is less relatively more, and Beijing, North China, Tianjin are many slightly than south China, East China.In 20 years from now on, acute myocardial infarction will be the dead No.1 cause of disease of patient in the worldwide.
Acute myocardial infarction is the elderly's a common acute disease, and is if can early diagnosis, significant to reducing case fatality rate.It is higher at acute phase mortality, and is especially early stage in morbidity.If handle in time with correct in a 1-2 hour after symptom takes place, just might make the patient out of danger.Patient to doubtful acute myocardial infarction; The inspection of will in time having an electro-cardiogram; And if observation is followed in attention and contrast can be done inspections such as white blood count and differential, erythrocyte sedimentation rate, glutamic-oxalacetic transaminease, lactic dehydrogenase, cretinephosphokinase, and is more useful to the early diagnosis acute myocardial infarction.
Creatine kinase isozyme (CK-MB) belongs to the stronger a kind of myocardium mark of specificity, and creatine kinase has 3 kinds of isodynamic enzymes, and they are respectively CK-MM (muscularities), CK-BB (brain type) and CK-MB (myocardium type).Creatine kinase in normal person's serum nearly all is CK-MM, and CK-MB appears at cardiac muscular tissue, accounts for 15～20%.Each tissue (except that gastrocnemius) of human body has only cardiac muscle to contain higher CK-MB, so isodynamic enzyme can be up to 100% to the specificity of diagnosing cardiac infarction, so CK-MB is the sero-enzyme index of diagnosing cardiac infarction the best up to now.Raise in 6 hours after the acute myocardial infarction and cause 2 times of ULN, 24 hours peakings fell and to cause baseline in 36 hours, and when heart stalk took place, serum CK-MB can increase 10～25 times, surpassed 10～12 times of the multiples that the CK total activity increases.Suffering under the situation of some other diseases; Like muscle disease, toxic shock, wound; Cerebrovas-cularaccident, hypothyroidism etc. also have and can in the middle of serum, detect CK-MB, but in these non-miocardial infarction diseases; Serum CK-MB accounts for the number percent average out to 2.5～7.5% (normal person＜2%) of total CK, all is lower than 7.5～19.5% of heart stalk.When acute myocardial infarction took place, creatine kinase can discharge in impaired cardiac muscle cell, caused CK-MB in the patients serum of acute myocardial infarction, obviously to raise.Usually reached the peak in 12～24 hours in miocardial infarction, and recovered normal at 48～72 hours.By the detection of CK-MB, can detect the activity of patient CK-MB, be very valuable for clinician's early diagnosis miocardial infarction is provided.
The acute myocardial infarction diagnostic method mainly contains: diagnosis is according to typical clinical manifestation, and distinctive ECG change and laboratory examination are diagnosed.ST section on the cardiogram raises that to occur with the Q ripple be the variation that two height are pointed out acute myocardial infarction; Yet only only about half of acute myocardial infarction case has these Electrocardiographic changes when going to a doctor; About 1/4 acute myocardial infarction patient lacks typical pectoralgia; By chance have only and to press close to infarct recording ecg when taking place, find in afterwards the inspection that perhaps long-standing pathologic Q ripple just possibly realize.Because of pectoralgia incredulity muscle infarction goes emergency treatment in the end is among the patient of acute myocardial infarction certainly; Half is arranged is the diagnosis that in initial Electrocardioscopy, can not get acute myocardial infarction; Therefore as far as most patients, the clinician must be through periodically measuring the diagnosis that cardiac marker comes the positive or negative acute myocardial infarction.And in various myocardium marks, CK-MB is that the AMI that the clinician trusts most detects " goldstandard ", and specificity is higher.At present, the method that CK-MB commonly used clinically detects is EUSA (ELISA) and radioimmunoassay method, and said method is time-consuming, require great effort, be unfavorable for universal and expensive.Exploitation is simple, quick acute miocardial infarction diagnostic method has crucial economic worth and social effect.
Immune colloidal gold technique is to be firstly appeared by Faulk and Taylor phase early 1970s, is used for immunoelectronmicroscopy at first.Colloidal gold-labeled method is as tracer label thing or developer with collaurum; In a kind of novel immunolabelling technique of antigen-antibody reaction, successfully be used for the fields such as manufacturing of Electronic Speculum, flow cytometer, Western blotting, protein staining, in-vitro diagnosis preparation now.Present golden labelling technique often cooperates with membrane carrier, forms specific immune detection mode, like immunity percolation test and immunity-chromatography test etc.Immuno-chromatographic test paper strip is exactly the important development direction that this technology is used for external quick diagnosis, is the novel detection technique that grows up on monoclonal antibody technique, colloidal gold immunochromatographimethod technology and the new material technology basis in modern times.This technical development in recent years is rapid, has particularly obtained widespread use in the bedside detection (POCT) in clinical diagnosis, like the detection of infectious disease, early pregnancy, cancer etc.
Utilize the detection method of collaurum to measure that CK-MB is developed as the diagnosis of acute myocardial infarction in the serum, it is limited to 5ng/mL under detecting.But, also be very necessary so exploitation can detect the sxemiquantitative colloid gold test paper of this CK-MB diagnosis gray area of CK-MB 5～10ng/mL for using this standard of 5ng/mL can not distinguish the acute myocardial infarction order of severity directly, fast clinically separately.All not having relevant test strips at present both at home and abroad sells.
Summary of the invention
The object of the invention: exploitation is simple, quick acute miocardial infarction diagnostic method has crucial economic worth and social value.Colloidal gold immunity chromatography is adopted in this experiment, sets up the method for fast detecting CK-MB.And can this CK-MB gray area scope of half-quantitative detection 5ng/mL～10ng/mL.
The present invention realizes through following technical scheme: adopt trisodium citrate reduction method to prepare colloid gold particle, the anti-CK-MB monoclonal antibody 1 of mark is also evenly coated on the glue gold pad, as the trace labelling thing.On nitrocellulose filter, the CK-MB monoclonal antibody 2 of two variable concentrations is fixed in two detection lines (being the T line), the sheep anti mouse two anti-nature controlling lines (being the C line) that are fixed in.Successively with sample pad, glue gold pad, nitrocellulose filter and absorbent filter assembling, be cut into colloid gold test paper and the test card of packing in.The gold labeling antibody combines to be trapped with corresponding antigen, antibody generation specificity and develops the color, and whether develops the color according to T line, C line and judges the yin and yang attribute result.
The inventive method comprises the steps:
One, colloidal gold solution preparation
1. prepare 1% chlorauric acid solution;
2. prepare 2% citric acid three sodium solution;
3. 0.02% chlorauric acid solution is heated to boiling, adds 2% trisodium citrate 2mL rapidly;
4. solution is by light blue, and dark blue, claret appears in heating again, continues to boil 10min;
Stop heating, continue to be stirred to room temperature.
Two, the preparation of colloid gold label thing
1. get two 1.5mL test tubes, add the 1mL colloidal gold solution respectively;
2. add an amount of borate buffer solution and be adjusted into 8.0 to pH;
3. add 20 μ g/mLCK-MB monoclonal antibodies 1, make it reach minimum protein concentration, mixing, vibration 30min;
4. the 10%BSA that adds 20 μ L, mixing, vibration 30min;
5.12000rpm centrifugal 5min absorbs supernatant gently;
6. the collaurum deposition that suspends loose with 1mL wash buffer solution weight;
7. repeat the operation of 5. steps;
8. repeat the operation of 6. steps;
9. repeat the operation of 5. steps;
10. being formulated in the OD of 540nm place (optical density) value with fix buffer is 0.5～1.0 colloid gold immune compound;
11. the plain film spot appearance of spun glass forms glue gold pad, vacuum freeze-drying 3 hours.
Three, on nitrocellulose filter, rule
1.T1 line uses CK-MB monoclonal antibody 2 line of concentration as 1.0mg/mL, is used to detect the CK-MB of 5ng/mL;
2.T2 line uses CK-MB monoclonal antibody 2 line of concentration as 0.6mg/mL, is used to detect the CK-MB of 10ng/mL;
3.C line is rule with 2.0mg/mL sheep anti mouse polyclonal antibody;
4. nitrocellulose filter was placed 40 ℃ of oven dryings 3 days.
Four, the assembling of colloidal gold strip
1. sample pad, glue gold pad, NC film and absorption pad 4 parts are assembled (seeing accompanying drawing 1) in order;
2. it is assembled and detect after the back is cut into the 4mm/ bar with scissors.
Five, detect
Test paper keeps flat, and sample is added on the sample pad of detector bar, because capillary effect, the chromatography direction of liquid combines to be trapped and develops the color with material on being fixed on T line, C line forward.Behind the 5min, judge the yin and yang attribute result according to the colour developing situation of T line, C line.The C line with near the detection of C line take out of existing redness be in the sample CK-MB level greater than 5ng/mL (seeing accompanying drawing 2); C line and two detect band all occurs red be in the sample CK-MB level greater than 10ng/mL (seeing accompanying drawing 3); Have only the C line red negative (seeing accompanying drawing 4) to occur, T line and C line all do not develop the color, and then test strips is invalid.
Detected object of the present invention is single and with strong points, and accuracy rate is high.Detection speed is fast, and required time is short, only needs 5min, does not need just can use the inventive method to detect through the professional of training, satisfies department's requirements of diagnosing cardiac infarction quickly and accurately such as hospital, outpatient service, and is convenient to basic unit's popularization and utilization.
Description of drawings
Fig. 1 is the diagram of embodiment of the invention test strips
Fig. 2 is the positive findings (the CK-MB level is greater than 5ng/mL) of embodiment of the invention test strips
Fig. 3 is the positive findings (the CK-MB level is greater than 10ng/mL) of embodiment of the invention test strips
Fig. 4 is the negative findings of embodiment of the invention test strips
Embodiment
Below in conjunction with accompanying drawing embodiments of the invention are elaborated: present embodiment provided detailed embodiment and concrete operating process, but protection scope of the present invention is not limited to following embodiment being to implement under the prerequisite with technical scheme of the present invention.
Among the following embodiment, the experimental technique of unreceipted actual conditions, usually according to normal condition, or the condition of advising according to manufacturer.
Jinsui River that this instance prepares 20nm with 2% citric acid three sodium solution earlier; And mark CK-MB monoclonal antibody 1 metal spraying mark pad; CK-MB monoclonal antibody 2, sheep anti mouse polyclonal antibody encapsulate respectively to detection line (T line), nature controlling line (C line); Be assembled into test strips then, put 37 ℃ of oven for drying and be cut into the 4mm/ bar, drying at room temperature is preserved subsequent use.
Embodiment
1. prepare CK-MB monoclonal antibody 1 and 2.And the required glassware of cleaning experiment.
2. the preparation of collaurum
With 0.02% chlorauric acid solution solution heated and boiled, add 2% trisodium citrate 2mL rapidly earlier;
Solution colour becomes dark bluely by light blue, continues heating and claret occurs, continues to boil 10min; Transparent claret occurs, stop heating, continue to be stirred to room temperature.The colloidal gold solution that has so just prepared 20nm.Use the Electronic Speculum microscopy then, guarantee that the gold grain for preparing makes its big or small consistent and uniform as far as possible, particle diameter is about 20nm, otherwise making again.
3. the preparation of colloid gold label thing
Get two 1.5mL test tubes, add the 1mL colloidal gold solution respectively; Be adjusted into 8.0 to pH to wherein adding an amount of borate buffer solution; Add 20 μ g/mL CK-MB monoclonal antibodies 1, make it reach minimum protein concentration, mixing, quick oscillation 30min on shaker; The 10%BSA that adds 20 μ L, mixing, vibration 30min; 12000rpm in hydro-extractor, centrifugal 5min absorbs supernatant gently; With the loose collaurum deposition of 1mL wash buffer solution weight suspension; 12000rpm in hydro-extractor, centrifugal 5min absorbs supernatant gently; With the loose collaurum deposition of 1mL wash buffer solution weight suspension; 12000rpm in hydro-extractor, centrifugal 5min absorbs supernatant gently; Being formulated in the OD of 540nm place (optical density) value with fix buffer is 0.5～1.0 colloid gold immune compound; Point sample on the plain film of spun glass forms glue gold pad, vacuum freeze-drying 3 hours.
4. the assembling of colloidal gold strip
On 2 strokes of detection lines of CK-MB monoclonal antibody (T line) with 1.0mg/mL and 0.6mg/mL, 2.0mg/mL sheep anti mouse polyclonal antibody is drawn on nature controlling line (C line) respectively at nitrocellulose filter.Then nitrocellulose filter was placed 40 ℃ of dryings of baking oven 3 days.Then various piece is assembled into test strips by accompanying drawing 1.
5. the use of colloidal gold strip and interpretation as a result
Before the detection, extract examinee's serum sample earlier.
Keep flat the test strips test paper then, sample is added on the sample pad of detector bar, because capillary effect, the chromatography direction of liquid combines to be trapped and develops the color with material on being fixed on T line, C line forward.Behind the 5min, judge the yin and yang attribute result according to the colour developing situation of T line, C line.The C line with near the detection of C line take out of existing redness be in the sample CK-MB level greater than 5ng/mL (seeing accompanying drawing 2); C line and two detect band all occurs red be in the sample CK-MB level greater than 10ng/mL (seeing accompanying drawing 3); Have only the C line red negative (seeing accompanying drawing 4) to occur, T line and C line all do not develop the color, and then test strips is invalid.
Embodiment is the CK-MB in the test sample directly, and method of application does not need professional training, and is easy to operate, quick, and 5min can obtain the result, can reach quick, easy, detect the purpose of CK-MB in time.
Claims (3)
1. method with two index line immunochromatography sxemiquantitative diagnosis creatine kinase isozymes; It is characterized in that; Adopt trisodium citrate reduction method to prepare colloid gold particle, the anti-CK-MB monoclonal antibody 1 of mark is also evenly coated on the collaurum pad, as the trace labelling thing.On nitrocellulose filter, the CK-MB monoclonal antibody 2 of two variable concentrations is fixed in two detection lines (being the T line), the sheep anti mouse two anti-nature controlling lines (being the C line) that are fixed in.Successively with sample pad, glue gold pad, nitrocellulose filter and absorbent filter assembling, be cut into colloid gold test paper and the test card of packing in.The gold labeling antibody combines to be trapped with corresponding antigen, antibody generation specificity and develops the color, and whether develops the color according to T line, C line and judges the yin and yang attribute result.
2. the method for the two index line immunochromatography sxemiquantitative diagnosis of a kind of usefulness according to claim 1 creatine kinase isozyme is characterized in that antibody line concentration is:
The T1 line uses CK-MB monoclonal antibody 2 line of concentration as 1.0mg/mL, is used to detect the CK-MB of 5ng/mL;
The T2 line uses CK-MB monoclonal antibody 2 line of concentration as 0.6mg/mL, is used to detect the CK-MB of 10ng/mL;
The C line is rule with 2.0mg/mL sheep anti mouse polyclone carrier;
Nitrocellulose filter was placed 40 ℃ of oven dryings 3 days.
3. the method for the two index line immunochromatography sxemiquantitative diagnosis of a kind of usefulness according to claim 1 creatine kinase isozyme; It is characterized in that; The antibody-solutions of utilization variable concentrations is rule on identical matrix, detects the method for the horizontal material of a plurality of variable concentrations with the collaurum method.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104337275A CN102539769A (en) | 2011-12-22 | 2011-12-22 | Method for semi-quantitative diagnosis of creatine kinase isoenzyme by double indicating line immuno-chromatography |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104337275A CN102539769A (en) | 2011-12-22 | 2011-12-22 | Method for semi-quantitative diagnosis of creatine kinase isoenzyme by double indicating line immuno-chromatography |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102539769A true CN102539769A (en) | 2012-07-04 |
Family
ID=46347167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011104337275A Pending CN102539769A (en) | 2011-12-22 | 2011-12-22 | Method for semi-quantitative diagnosis of creatine kinase isoenzyme by double indicating line immuno-chromatography |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102539769A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107045057A (en) * | 2017-04-11 | 2017-08-15 | 内蒙古自治区农牧业科学院 | A kind of ox source creatine kinase isozyme colloidal gold immune chromatography rapid detecting test paper strip |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030119203A1 (en) * | 2001-12-24 | 2003-06-26 | Kimberly-Clark Worldwide, Inc. | Lateral flow assay devices and methods for conducting assays |
| CN201087837Y (en) * | 2007-03-30 | 2008-07-16 | 万华普曼生物工程有限公司 | Human myohemoglobin/creatine kinase isoenzyme/myocardium calcium protein I diagnosis test paper |
| EP1787121B1 (en) * | 2004-07-29 | 2010-08-25 | Relia Diagnostic Systems, LLC | Lateral flow system and assay |
| CN101915833A (en) * | 2010-09-10 | 2010-12-15 | 中国科学院东北地理与农业生态研究所 | Semi-quantitative rapid detection test paper for immunoglobulin G in bovine colostrum and products thereof and preparation method thereof |
| CN102135498A (en) * | 2010-01-25 | 2011-07-27 | 刘凤鸣 | Semi-quantitative colloidal metal detection technology taking multi-capture property as characteristic and preparation method and use thereof |
| CN102221612A (en) * | 2011-06-10 | 2011-10-19 | 正元盛邦(天津)生物科技有限公司 | Method for employing double indicatrix immunochromatography by semi-quantity to diagnose carcinoembryonic antigen |
-
2011
- 2011-12-22 CN CN2011104337275A patent/CN102539769A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030119203A1 (en) * | 2001-12-24 | 2003-06-26 | Kimberly-Clark Worldwide, Inc. | Lateral flow assay devices and methods for conducting assays |
| EP1787121B1 (en) * | 2004-07-29 | 2010-08-25 | Relia Diagnostic Systems, LLC | Lateral flow system and assay |
| CN201087837Y (en) * | 2007-03-30 | 2008-07-16 | 万华普曼生物工程有限公司 | Human myohemoglobin/creatine kinase isoenzyme/myocardium calcium protein I diagnosis test paper |
| CN102135498A (en) * | 2010-01-25 | 2011-07-27 | 刘凤鸣 | Semi-quantitative colloidal metal detection technology taking multi-capture property as characteristic and preparation method and use thereof |
| CN101915833A (en) * | 2010-09-10 | 2010-12-15 | 中国科学院东北地理与农业生态研究所 | Semi-quantitative rapid detection test paper for immunoglobulin G in bovine colostrum and products thereof and preparation method thereof |
| CN102221612A (en) * | 2011-06-10 | 2011-10-19 | 正元盛邦(天津)生物科技有限公司 | Method for employing double indicatrix immunochromatography by semi-quantity to diagnose carcinoembryonic antigen |
Non-Patent Citations (1)
| Title |
|---|
| 刘宇，周荣斌: "20110615胶体金免疫层析法检测心肌标志物在诊断急性心肌梗死中的应用", 《CHINESE GENERAL PARCTICE》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107045057A (en) * | 2017-04-11 | 2017-08-15 | 内蒙古自治区农牧业科学院 | A kind of ox source creatine kinase isozyme colloidal gold immune chromatography rapid detecting test paper strip |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105588939B (en) | MPO, H FABP and cTnT joint-detections device and preparation method | |
| Von Euler et al. | Diagnosis of pheochromocytoma by fluorimetric estimation of adrenaline and noradrenaline in urine | |
| CN104634980B (en) | The super quick detection kit of cardiac muscle troponin I and super quick detection method | |
| CN101105497B (en) | Cardiac muscle troponin I detection reagent kit and its preparation method | |
| US20190219569A1 (en) | Fluorescence immunochromatographic detection card and a preparation method therefor and use thereof | |
| CN102221612A (en) | Method for employing double indicatrix immunochromatography by semi-quantity to diagnose carcinoembryonic antigen | |
| CN104569433A (en) | Myocardial infarction rapid detection kit and preparation method thereof | |
| CN101275954B (en) | Breast cancer early warning chip for easily rapid measuring human I type thymidine kinase gene protein | |
| CN102565426A (en) | Method for diagnosing luteinizing hormone (LH) in semi-quantitative mode by employing double-indicatrix immunochromatography | |
| CN104142399B (en) | A kind ofly utilize colloidal gold immunochromatographimethod technology quantitatively test strips detecting Serum Pepsinogen and its preparation method and application | |
| CN102841207A (en) | Fluorescent immune chromatographic test strip for quantitively detecting troponin I and preparation method thereof | |
| CN101271108A (en) | Myocardial infarct early diagnosis liquid phase chip and method for producing the same | |
| CN102087294B (en) | Immunochromatographic test strip for rapidly detecting malaria and preparation method thereof | |
| CN102565417A (en) | Method for diagnosing cardiac troponin I (cTn I) in semi-quantitative mode by employing double-indicatrix immunochromatography | |
| CN108414769A (en) | A kind of protein chip and preparation method thereof for heart failure marker detection | |
| CN105785028A (en) | Rapid diagnosis kit for detecting novel human cardiac failure marker ST2 | |
| CN112881708B (en) | Colloidal gold immunochromatographic test paper for detecting human amyloid-beta and preparation thereof | |
| CN107271692B (en) | Fluorescent microsphere for marking specific high-affinity recombinant antibody and application thereof | |
| CN103389374B (en) | Micro whole blood application of sample method detects mycoplasma pneumoniae colloidal gold kit | |
| CN102539769A (en) | Method for semi-quantitative diagnosis of creatine kinase isoenzyme by double indicating line immuno-chromatography | |
| CN102539783A (en) | Method for semi-quantitatively diagnosing myoglobin with double-index-line immunochromatography | |
| CN101408547A (en) | Gold mark reagent kit for detecting angiostrongyliasis cantonensis and preparing method thereof | |
| CN106443004A (en) | Time-resolved fluorescence immunochromatographic reagent for rapidly, quantitatively and simultaneously detecting cTnI and H-FABP, and preparation method thereof | |
| CN102565407A (en) | Method for semi-quantitative diagnosis of clenbuterol hydrochloride through double-indicating line immunochromatography | |
| CN102221617A (en) | Early stage prostate cancer semi-quantitative diagnosis method utilizing double indication line immunity chromatography |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120704 |